Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bionovo Inc.

www.bionovo.com

Latest From Bionovo Inc.

Equity Agreement With LLC Gives MediciNova Potential To Move Two Lead Programs Into Phase III

A $20 million common stock purchase agreement with Aspire Capital provides MediciNova some breathing room as it attempts to negotiate partnerships around a pair of mid-stage small-molecule candidates.

BioPharmaceutical United States

Moribund Bionovo flogs stock before exiting Nasdaq

Emeryville, California-based Bionovo may have gasped its last breath this week with a common stock offering and sale of warrants that is expected to generate less than a million dollar four days after the pharmaceutical firm announced that it will cut management salaries and reduce its workforce by 90 percent.

Cancer

Deals Shaping the Medical Industry (03/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions.

Dr Richard Weiner joins Bionovo's board

Dr Richard Weiner has joined Bionovo's scientific advisory board. He is an emeritus professor in the department of obstetrics, gynaecology and reproductive sciences at the University of California School of Medicine.

Companies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bionovo Inc.
  • Senior Management
  • Isaac Cohen, CEO
    Tom Chesterman, SVP, CFO
    Mary Tagliaferri, MD, Pres. & CMO
  • Contact Info
  • Bionovo Inc.
    Phone: (510) 601-2000
    5858 Horton St.
    Ste. 400
    Emeryville, CA 94608
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register